CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding CytomX Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 83 | 103 | +20 |
| Shares | 133.3M | 137.4M | +4.12M (+3.1%) |
| Value | $302.6M | $438.4M | +$135.8M (+44.9%) |
New holders (32)
Institutions that held CytomX Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (12)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Franklin Resources Inc | 5,769,230 | $13.1M |
| Fairmount Funds Management LLC | 3,896,582 | $8.85M |
| Soleus Capital Management, L.P. | 1,304,300 | $2.96M |
| Readystate Asset Management LP | 844,643 | $1.92M |
| EAM Investors, LLC | 254,580 | $577.9K |
| Bridgeway Capital Management, LLC | 126,000 | $286.0K |
| Commonwealth Equity Services, LLC | 53,243 | $121.0K |
| Bayesian Capital Management, LP | 50,117 | $113.8K |
| Two Sigma Securities, LLC | 47,311 | $107.4K |
| Lazard Asset Management LLC | 43,316 | $98.0K |
| Virtu Financial LLC | 35,136 | $80.0K |
| Federated Hermes, Inc. | 398 | $903 |